Clinical Trials on Influenza Virus Infection in Belgium

Total 1523 results

Sciensano
Institute of Tropical Medicine, Belgium; Erasme University Hospital; Mensura...

Completed

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine (REDU-VAC)

Covid19

Belgium
Universiteit Antwerpen
Vrije Universiteit Brussel; Université Libre de Bruxelles; Sciensano

Active, not recruiting

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium (PREGCOVAC)

Covid19

Belgium
University of Liege
Laboratoires SMB S.A.

Completed

Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

Covid19

Belgium
Murielle Surquin

Completed

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Covid19

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Surgical Face Mask Effects in Patients With COVID-19

Covid19

Belgium
Jessa Hospital

Completed

Bacterial Surinfections in COVID-19 ICU Patients

Covid19

Belgium
Hanane EL KENZ

Completed

Reduction of COVID 19 Transmission to Health Care Professionals

COVID 19

Belgium
Jessa Hospital

Completed

Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia

COVID 19

Belgium
GlaxoSmithKline

Completed

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Hepatitis B | Hepatitis A

Belgium, Czech Republic
GlaxoSmithKline

Completed

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

Hepatitis B

Belgium
Novosanis NV

Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (POC_VAX-ID)

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

Hepatitis B Disease

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Hepatitis C | HIV

Belgium
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector

Covid19 | SARS-CoV-2

Belgium
OSE Immunotherapeutics

Recruiting

To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults (COVEPIT 3)

Coronavirus Disease (COVID-19)

Belgium
Aquilon Pharmaceuticals S.A.

Terminated

Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms (SIROCCO-1)

Covid19

Belgium
University Hospital, Ghent
University Ghent

Completed

SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients

Covid19 | Children, Only

Belgium
Vrije Universiteit Brussel
Universitair Ziekenhuis Brussel

Completed

COVID-19 and the Brain

Covid19 | Brain | fMRI | Neurocognition

Belgium
Hasselt University

Unknown

Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA

Hepatitis C | Drug Use

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
Janssen Sciences Ireland UC

Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Belgium, United Kingdom, France, Italy, Germany, Spain, Poland
Université Catholique de Louvain

Completed

Health Care Use During the Covid19 Crisis (US3R)

Health Care Utilization

Belgium
Sciensano
Institute of Tropical Medicine, Belgium

Completed

COVID-19 Among Healthcare Workers in Belgian Hospitals (COVHECBEHO)

COVID-19 | SARS-CoV-2

Belgium
Institute of Tropical Medicine, Belgium

Completed

COVID-19 Seroprevalence Study in ITM Staff (CovAb)

Covid19

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven (PROFITH)

Prosthetic Joint Infection | Hip Prosthesis Infection

Belgium
Centre Hospitalier Universitaire Saint Pierre
AbbVie; Gilead Sciences; Cepheid; Réseau Hépatite C Bruxelles

Completed

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Hepatitis C, Chronic

Belgium
University of Liege

Active, not recruiting

Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs (IDOLTIB)

HIV Infections

Belgium
Institute of Tropical Medicine, Belgium
Sciensano

Completed

Development and Implementation of an HIV-testing Intervention for Primary Care in Belgium

HIV Infections

Belgium
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

HIV Infections

Belgium
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Completed

Pharmacogenetics of Antiretroviral Drugs

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

HIV Infections

Belgium
Universitair Ziekenhuis Brussel

Unknown

poSt Covid-19 Infection centraL Sensitisation 2 (SILENT 2)

Covid19

Belgium
University Hospital, Antwerp

Withdrawn

Covid-19 Long-term Revalidation Follow-up (Colonel)

Covid19

Belgium
University Hospital, Antwerp

Enrolling by invitation

Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis

Respiratory Viral Infection | Respiratory Morbidity | Cystic Fibrosis in Children | Respiratory Bacterial Infection | Inflammation Lungs

Belgium
Université Catholique de Louvain

Active, not recruiting

Study of Children's Well-being After the COVID-19 Pandemic in Belgian French-speaking Primary Schools (DYNAtracs)

Well-being

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C

Hepatitis C, Chronic

Belgium
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

HIV Infections

Belgium
Jessa Hospital

Completed

Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

COVID-19

Belgium
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (nOPV2M4a)

Poliomyelitis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

Covid19 | Hypoxemia

Belgium
GlaxoSmithKline

Completed

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

HIV Infections | AIDS

Belgium
International Partnership for Microbicides, Inc.

Completed

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

HIV Infections | HIV-1

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

Hepatitis B

Denmark, Belgium
University Ghent

Completed

Community Health Workers Against COVID19

Covid 19 | Mental Health Impairment | Social Isolation

Belgium
Jules Bordet Institute
Roche Pharma AG

Terminated

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 (I-SPARC)

Cancer

Belgium
Grand Hôpital de Charleroi

Completed

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

Covid19

Belgium
Grand Hôpital de Charleroi

Completed

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Covid19

Belgium
Brugmann University Hospital

Completed

Surgery in the Time of COVID-19 Pandemic

Covid19

Belgium
Theravectys S.A.

Completed

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

HIV Infection

France, Belgium

3

Subscribe